Engineering discoidal polymeric nanoconstructs with enhanced magneto-optical properties for tumor imaging.
暂无分享,去创建一个
Jaehong Key | Francesco Gentile | Paolo Decuzzi | Meng Zhong | P. Decuzzi | J. Key | F. Gentile | M. Landis | S. Aryal | Santosh Aryal | Jeyarama S Ananta | Melissa D Landis | J. Ananta | Meng Zhong
[1] Mauro Ferrari,et al. Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[2] Mauro Ferrari,et al. Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast , 2010, Nature nanotechnology.
[3] Giuseppe Pascazio,et al. The preferential targeting of the diseased microvasculature by disk-like particles. , 2012, Biomaterials.
[4] S. Nie,et al. A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. , 2010, ACS nano.
[5] Samir Mitragotri,et al. Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[6] Wadih Arap,et al. Probing the structural and molecular diversity of tumor vasculature. , 2002, Trends in molecular medicine.
[7] H. Maeda,et al. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.
[8] D. Medina,et al. A new approach to mammary tumorigenesis in rodents , 1969, Cancer.
[9] Mauro Ferrari,et al. Design of bio-mimetic particles with enhanced vascular interaction. , 2009, Journal of biomechanics.
[10] T. Desai,et al. Surfactant-free, drug-quantum-dot coloaded poly(lactide-co-glycolide) nanoparticles: towards multifunctional nanoparticles. , 2008, ACS Nano.
[11] M Ferrari,et al. The adhesive strength of non-spherical particles mediated by specific interactions. , 2006, Biomaterials.
[12] Jeffrey M. Rosen,et al. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features , 2009, Proceedings of the National Academy of Sciences.
[13] Thomas L Rish,et al. A study of drug release from homogeneous PLGA microstructures. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[14] M. Ferrari. Cancer nanotechnology: opportunities and challenges , 2005, Nature Reviews Cancer.
[15] D. Discher,et al. Shape effects of filaments versus spherical particles in flow and drug delivery. , 2007, Nature nanotechnology.
[16] Jenny C. Chang,et al. Patient-derived breast tumor xenografts facilitating personalized cancer therapy , 2013, Breast Cancer Research.
[17] Samir Mitragotri,et al. Physical approaches to biomaterial design. , 2009, Nature materials.
[18] Mauro Ferrari,et al. Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. , 2008, Nature nanotechnology.
[19] M Ferrari,et al. The effect of shape on the margination dynamics of non-neutrally buoyant particles in two-dimensional shear flows. , 2008, Journal of biomechanics.
[20] Omid C. Farokhzad,et al. α(V)β(3) integrin-targeted PLGA-PEG nanoparticles for enhanced anti-tumor efficacy of a Pt(IV) prodrug. , 2012, ACS nano.
[21] R. Auerbach. Vascular endothelial cell differentiation: organ-specificity and selective affinities as the basis for developing anti-cancer strategies. , 1991, International Journal of Radiation Biology.
[22] Susan G Hilsenbeck,et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. , 2008, Journal of the National Cancer Institute.
[23] Mauro Ferrari,et al. Nanotechnology for breast cancer therapy , 2009, Biomedical microdevices.
[24] R. Jain,et al. Delivering nanomedicine to solid tumors , 2010, Nature Reviews Clinical Oncology.
[25] William D Rooney,et al. Superparamagnetic Iron Oxide Nanoparticles: Diagnostic Magnetic Resonance Imaging and Potential Therapeutic Applications in Neurooncology and Central Nervous System Inflammatory Pathologies, a Review , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[26] Robert Langer,et al. Impact of nanotechnology on drug delivery. , 2009, ACS nano.
[27] Anderson,et al. Biodegradation and biocompatibility of PLA and PLGA microspheres. , 1997, Advanced drug delivery reviews.
[28] M. Ferrari,et al. Enhanced MRI relaxivity of Gd(3+) -based contrast agents geometrically confined within porous nanoconstructs. , 2012, Contrast media & molecular imaging.
[29] S M Moghimi,et al. Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective. , 2012, Annual review of pharmacology and toxicology.
[30] Thomas L Andresen,et al. Liposome imaging agents in personalized medicine. , 2012, Advanced drug delivery reviews.
[31] W. Arap,et al. Display technologies: Application for the discovery of drug and gene delivery agents , 2006, Advanced Drug Delivery Reviews.
[32] Kyung-Hwa Yoo,et al. Multifunctional nanoparticles for combined doxorubicin and photothermal treatments. , 2009, ACS nano.
[33] Ralph Weissleder,et al. Multifunctional magnetic nanoparticles for targeted imaging and therapy. , 2008, Advanced drug delivery reviews.
[34] Joseph M DeSimone,et al. Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials. , 2005, Journal of the American Chemical Society.
[35] C. Robic,et al. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. , 2008, Chemical reviews.
[36] J. M. Harris,et al. Effect of pegylation on pharmaceuticals , 2003, Nature Reviews Drug Discovery.
[37] B. Xiang,et al. Clusters of superparamagnetic iron oxide nanoparticles encapsulated in a hydrogel: a particle architecture generating a synergistic enhancement of the T2 relaxation. , 2011, ACS nano.
[38] Vladimir Torchilin,et al. Tumor delivery of macromolecular drugs based on the EPR effect. , 2011, Advanced drug delivery reviews.
[39] Mary E Napier,et al. The effect of particle size on the biodistribution of low-modulus hydrogel PRINT particles. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[40] C. Serna,et al. Effect of nanoparticle and aggregate size on the relaxometric properties of MR contrast agents based on high quality magnetite nanoparticles. , 2009, The journal of physical chemistry. B.
[41] Walter Hu,et al. Shape-specific polymeric nanomedicine: emerging opportunities and challenges , 2011, Experimental biology and medicine.
[42] Matthew D. McDermott,et al. The hydrogel template method for fabrication of homogeneous nano/microparticles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[43] S. Wise. Nanocarriers as an emerging platform for cancer therapy , 2007 .
[44] Sei-Young Lee,et al. Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows , 2009, Nanotechnology.
[45] W. Parak,et al. Composite nanoparticles take aim at cancer. , 2008, ACS nano.
[46] Shiladitya Sengupta,et al. Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system , 2005, Nature.
[47] Joseph M. DeSimone,et al. Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles , 2011, Proceedings of the National Academy of Sciences.
[48] Mauro Ferrari,et al. Intravascular Delivery of Particulate Systems: Does Geometry Really Matter? , 2008, Pharmaceutical Research.
[49] Samir Mitragotri,et al. Role of target geometry in phagocytosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.